Also known as: Rubeola (Measles)
Measles is a highly contagious viral illness characterized by high fever, cough, and a distinctive red rash. Despite being vaccine-preventable, it remains a significant cause of childhood mortality worldwide.
Measles is one of the most contagious diseases known to humanity — a single infected person can spread it to 12-18 susceptible individuals. Before widespread vaccination, measles caused an estimated 2.6 million deaths annually. Even today, it kills over 100,000 people per year, mostly children under 5 in developing countries.
The measles virus spreads through respiratory droplets and can remain airborne in an enclosed space for up to 2 hours after an infected person has left. The incubation period is typically 10-14 days from exposure to the onset of fever.
The characteristic rash appears about 3-5 days after symptoms begin, starting on the face and spreading downward. Koplik spots (tiny white spots on the inner cheeks) are pathognomonic and appear 2-3 days before the rash.
The MMR (measles, mumps, rubella) vaccine is approximately 97% effective after two doses and has prevented an estimated 56 million deaths between 2000 and 2021.
People with Measles often experience the following symptoms.
High fever (up to 40.5°C), cough, coryza (runny nose), and conjunctivitis (the 'three Cs') develop before the rash. This phase lasts 2-4 days.
Small white or bluish-white spots on the buccal mucosa (inner cheeks) that are unique to measles. They appear 2-3 days before the rash and fade as the rash develops.
A red, blotchy rash that begins on the face and behind the ears, then spreads to the trunk and limbs over 3-4 days. It may become confluent and typically lasts 5-6 days.
Fever often peaks at 40-40.5°C around the time the rash appears and falls 3-4 days later. Persistent high fever may suggest complications.
Certain factors may increase your likelihood of developing Measles.
Common approaches to managing measles. Always consult a healthcare provider for personalized treatment.
There is no specific antiviral therapy for measles. Treatment focuses on rest, hydration, and fever management with acetaminophen or ibuprofen.
WHO recommends vitamin A for all children with measles, as it significantly reduces mortality and complication rates, particularly in areas with vitamin A deficiency.
Antibiotics for secondary bacterial infections (pneumonia, otitis media). Hospitalization for encephalitis, severe pneumonia, or dehydration.
MMR vaccine within 72 hours or immunoglobulin within 6 days of exposure may prevent or modify disease in susceptible contacts.
Clinical diagnosis based on the characteristic presentation (fever, three Cs, Koplik spots, rash). Laboratory confirmation involves measles-specific IgM antibodies or detection of measles RNA by RT-PCR from throat swab or urine. Measles is a notifiable disease in most countries.
Seek medical attention immediately if you suspect measles, especially if there is difficulty breathing, persistent high fever, seizures, or signs of confusion — complications can develop rapidly.
Steps that may help reduce the risk of developing or worsening measles.
MMR vaccination (2-dose series for children at 12-15 months and 4-6 years)
Ensure vaccination before international travel
Post-exposure vaccination within 72 hours
Isolation of confirmed cases for 4 days after rash onset
If left untreated or poorly managed, measles may lead to:
Vaccination coverage must exceed 95% for herd immunity. Outbreaks continue in communities with low vaccination rates and in countries with limited vaccine access.
Rarely. About 3% of people who receive two doses may still be susceptible. Breakthrough cases tend to be milder.
Two doses of MMR vaccine provide long-lasting, likely lifelong immunity in the vast majority of recipients.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.